Filter Vision Public Company Limited (FVC.BK)
Bangkok, TH
Filter Vision Public Company Limited, a Bangkok-headquartered enterprise founded in 1995, delivers comprehensive pure water treatment systems throughout Thailand. Its activities span the engineering, assembly, deployment, maintenance, and supply of these systems. The company's diverse water filtration offerings feature purification units, an array of filter housings—including single and multi-cartridge, bag, and standard cartridge types—and automated filters for iron/manganese removal, sand/multimedia processing, water softening, and catalytic oxidation. They also provide various filter cartridges such as spun, membrane, pleated, string wound, polypropylene, and carbon block options, alongside filter bags and bag vessel assemblies. Additionally, specialized water filters are available for food service, vending, coffee and ice machines, and general drinking water applications. Beyond filtration, Filter Vision supplies disinfection and sanitization solutions. This includes UV sterilizers and systems, ozone generators and spray bottles, barrier-free versacoolers, infection control hydro-ozonizers, bacteria-free ice systems, and complete ultraviolet disinfection setups. The company further extends its product line to food and beverage equipment, offering items like kettles, sandwich makers, steamers, food warmers, warmer machines, fryers, grill fryers, ice making machines, and drink dispensers, complemented by rainwater harvesting systems and associated accessories. A crucial aspect of their operations involves medical services. Filter Vision operates clinics for dialysis treatments and dedicated hemodialysis centers assisting patients with end-stage chronic kidney disease. They are also active in the distribution, leasing, and servicing of vital medical tools, diagnostic equipment, and a wide range of medical supplies and appliances. Their clientele encompasses commercial and residential users, industrial clients, original equipment manufacturers (OEMs), and the medical service industry.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.13% | +0.00% | -11.43% | -29.55% | -31.11% | -36.73% | -29.55% | -67.37% | -69.61% | -83.60% | -86.22% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Industrial - Pollution & Treatment Controls: +8.0%+10.4% ★ Q1'26: +90.6% (vs Q1'25)
-
EPS growth Industrial - Pollution & Treatment Controls: +15.8%-16.3% Q1'26: -131.4% (vs Q1'25)
-
FCF margin FCF growth · Industrial - Pollution & Treatment Controls: +35.7%-18.4% Q1'26: +0.8% (vs Q1'25)
-
EBIT margin Industrial - Pollution & Treatment Controls: +10.2%+7.8% Q1'26: +3.2% (vs Q1'25)
-
ROIC Industrial - Pollution & Treatment Controls: +6.6%+3.1% Q1'26: +2.0% (vs Q1'25)
-
Share dilution Industrial - Pollution & Treatment Controls: 0.0%+91.0% Q1'26: +298.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Industrial - Pollution & Treatment Controls: -0.39×4.08× Q1'26: 4.45× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-20 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-19 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-18 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-15 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-14 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-13 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-11 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-08 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-07 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-06 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-05 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-30 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Panchit Chimpalee | Assistant GM of Accounting & Financial Department, Company Secretary, Head of IR and Director | — | female |
| Rathaphon Tatong | B1 Business Manager | — | male |
| Rattapon Thathong | Executive Director & B1 Business Manager | — | male |
| Somchai Hongsa | Executive Director and Project & Innovation Manager | — | male |
| Thanapa Techakasem | Administration Manager & Executive Director | — | female |
| Wijit Techakasem | Chairman of Executive Board, MD & Executive Director | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for FVC.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
